Brief: Aquestive Therapeutics, Inc. Q3 revenue USD 13.002 million
06/11/2023 21:41
Nov 6 (Reuters) - Aquestive Therapeutics, Inc. Q3 income from operations USD -2.377 million. * Q3 adjusted EBITDA USD -1.339 million * Q3 revenue USD 13.002 million vs. IBES estimate USD 11.5 million * Q3 pretax profit USD -2.175 million * Q3 net income USD -2.035 million
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Inc - Enters Five-Year Term Loan Facility Of Up To $150 Million On May 12, 2026 - SEC Filing
Aquestive Therapeutics Q1 revenue jumps on higher license and royalty income
Brief: Aquestive Therapeutics Announces Completion Of Type A Meeting With FDA For Anaphylm™ (Dibutepinephrine) Sublingual Film
Aquestive misses Q4 revenue estimates, EBITDA loss widens
Brief: Aquestive Therapeutics, Inc. Q4 Net Income USD -31.86 Million